Published Scientific Articles
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Concarlo in the News
Life Sciences Review special edition on BioTech Startup 2022
US biotech start-up set to have huge impact on breast cancer treatment landscape
Concarlo: targeting proliferation and resistance in one go
Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer
Webinars & Talks
Awards
“The reward for work well done is the opportunity to do more”
—Jonas Salk
RESI’s Innovator’s Pitch Challenge Winner
Princeton University Women’s Showcase
The 50 Most admired companies: CIO Bio
Top 100 entreprenuers: Alumni List
Top Biotech Startup 2022
Awarded by: Life Sciences Review
